Charlie's Holdings' Q1 Loss Widens to $1.5M Amid Debt Pressures
Ticker: CHUC · Form: 10-Q · Filed: Jun 27, 2025 · CIK: 1134765
| Field | Detail |
|---|---|
| Company | Charlie'S Holdings, Inc. (CHUC) |
| Form Type | 10-Q |
| Filed Date | Jun 27, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Medicinal Chemicals, Botanical Products, Quarterly Earnings, Debt Financing, Net Loss, Liquidity Risk, SEC Filing
Related Tickers: CHUC
TL;DR
**CHUC is bleeding cash and facing immediate debt deadlines; steer clear unless you like high-stakes gambles.**
AI Summary
Charlie's Holdings, Inc. (CHUC) reported a net loss of $1.5 million for the three months ended March 31, 2025, a significant increase from the $0.9 million net loss in the same period of 2024. The company's strategic outlook includes a focus on managing its debt obligations, particularly a $1.5 million note payable to Michael King due April 28, 2025, and a $1.0 million loan due April 28, 2025. Key business changes include the ongoing management of the Pinnacle Receivables Financing Agreement, which had a balance of $1.0 million as of April 16, 2025. Risks are highlighted by the company's reliance on financing agreements and the potential impact of future asset purchase agreements, such as the one dated May 29, 2025. The company also continues to incur lease obligations for its corporate headquarters in Costa Mesa, CA, and a facility in Williamsville, NY, with the corporate lease expiring in November 2024.
Why It Matters
For investors, CHUC's widening net loss and significant near-term debt maturities, including a $1.5 million note to Michael King, signal heightened financial risk and potential dilution if new equity is issued. Employees face uncertainty given the company's financial strain and ongoing operational adjustments. Customers might see impacts on product availability or innovation if the company's financial health deteriorates further. In the competitive landscape of medicinal chemicals and botanical products, CHUC's struggles could allow more financially stable competitors to gain market share, making its ability to secure new financing or execute asset sales critical for survival.
Risk Assessment
Risk Level: high — The company reported a net loss of $1.5 million for Q1 2025, an increase from $0.9 million in Q1 2024, indicating deteriorating financial performance. Furthermore, CHUC faces immediate liquidity challenges with a $1.5 million note payable to Michael King and a $1.0 million loan both due on April 28, 2025, alongside a $1.0 million balance on the Pinnacle Receivables Financing Agreement as of April 16, 2025.
Analyst Insight
Investors should exercise extreme caution and consider divesting CHUC shares due to the widening losses and critical near-term debt maturities. Monitor closely for announcements regarding successful refinancing or asset sales, as failure to address these obligations could lead to significant financial distress or bankruptcy.
Key Numbers
- $1.5M — Net Loss (for the three months ended March 31, 2025, up from $0.9M in Q1 2024)
- $1.5M — Note Payable (due to Michael King by April 28, 2025)
- $1.0M — Loan Payable (due by April 28, 2025)
- $1.0M — Pinnacle Receivables Financing Agreement Balance (as of April 16, 2025)
- 2025-03-31 — Period End Date (date of the reported financial results)
- 2025-06-27 — Filing Date (date the 10-Q was filed)
Key Players & Entities
- Charlie's Holdings, Inc. (company) — filer of the 10-Q
- Michael King (person) — recipient of a $1.5 million note payable
- Pinnacle Receivables Financing Agreement (company) — financing agreement with a $1.0 million balance
- 03 Life Sciences (company) — organization name associated with the filer
- True Drinks Holdings, Inc. (company) — former company name
- BAZI INTERNATIONAL, INC. (company) — former company name
- XELR8 HOLDINGS, INC. (company) — former company name
- SEC (regulator) — regulator for 10-Q filings
FAQ
What was Charlie's Holdings, Inc.'s net loss for Q1 2025?
Charlie's Holdings, Inc. reported a net loss of $1.5 million for the three months ended March 31, 2025, which is an increase from the $0.9 million net loss reported in the same period of 2024.
What are the key debt obligations facing Charlie's Holdings, Inc.?
Charlie's Holdings, Inc. faces a $1.5 million note payable to Michael King and a $1.0 million loan, both due on April 28, 2025. Additionally, the Pinnacle Receivables Financing Agreement had a balance of $1.0 million as of April 16, 2025.
When does Charlie's Holdings, Inc.'s corporate headquarters lease expire?
Charlie's Holdings, Inc.'s corporate headquarters lease in Costa Mesa, CA, which commenced on November 1, 2019, is set to expire in November 2024.
What is the primary risk highlighted in Charlie's Holdings, Inc.'s 10-Q?
The primary risk highlighted is the company's ability to manage its significant near-term debt obligations, specifically the $1.5 million note and $1.0 million loan due April 28, 2025, which could impact its liquidity and ongoing operations.
How has Charlie's Holdings, Inc.'s financial performance changed year-over-year?
Charlie's Holdings, Inc.'s financial performance has deteriorated, with the net loss widening from $0.9 million in Q1 2024 to $1.5 million in Q1 2025.
What is the significance of the Asset Purchase Agreement mentioned in the filing?
The Asset Purchase Agreement, dated May 29, 2025, indicates potential strategic changes or divestitures for Charlie's Holdings, Inc., which could impact its asset base and future operational structure.
What is the Central Index Key (CIK) for Charlie's Holdings, Inc.?
The Central Index Key (CIK) for Charlie's Holdings, Inc. is 0001134765, which is used by the SEC to identify the company.
What industry does Charlie's Holdings, Inc. operate in?
Charlie's Holdings, Inc. operates in the Medicinal Chemicals & Botanical Products industry, as indicated by its Standard Industrial Classification (SIC) code 2833.
What should investors consider regarding Charlie's Holdings, Inc.'s stock?
Investors should consider the high financial risk due to widening losses and immediate debt maturities. The company's ability to secure new financing or execute asset sales will be crucial for its future viability.
Who is the CEO of Charlie's Holdings, Inc.?
The filing indicates a Chief Executive Officer was in place as of June 15, 2023, but does not specify the individual's name in the provided excerpt.
Risk Factors
- Near-Term Debt Maturities [high — financial]: The company faces significant debt obligations with a $1.5 million note payable to Michael King and a $1.0 million loan both due on April 28, 2025. Failure to meet these obligations could lead to financial distress.
- Reliance on Financing Agreements [medium — financial]: Charlie's Holdings relies heavily on financing agreements, such as the Pinnacle Receivables Financing Agreement with a $1.0 million balance as of April 16, 2025. Changes in the terms or availability of such financing pose a risk.
- Potential Impact of Future Asset Purchases [medium — financial]: The company is involved in future asset purchase agreements, such as one dated May 29, 2025. The financial implications and successful integration of these agreements are uncertain and could impact financial stability.
- Lease Obligations [low — operational]: The company has ongoing lease obligations for its corporate headquarters in Costa Mesa, CA, and a facility in Williamsville, NY. The corporate lease expires in November 2024, requiring potential renegotiation or relocation costs.
Industry Context
Charlie's Holdings operates within the medicinal chemicals and botanical products sector (SIC 2833). This industry is characterized by rigorous regulatory oversight, significant research and development costs, and competitive pressures from both established players and emerging companies. Trends include increasing demand for specialized botanical ingredients and evolving consumer preferences for natural and health-focused products.
Regulatory Implications
As a company in the medicinal chemicals and botanical products sector, Charlie's Holdings is subject to stringent regulations from bodies like the FDA. Compliance with manufacturing standards, product safety, and labeling requirements is critical. Any changes in regulatory frameworks or enforcement actions could significantly impact operations and product viability.
What Investors Should Do
- Monitor Debt Repayment
- Assess Financing Dependence
- Evaluate Future Asset Purchases
- Analyze Lease Expirations
Key Dates
- 2025-03-31: Quarter End Date — Represents the period for which the financial results are reported, showing a net loss of $1.5 million.
- 2025-04-28: Note Payable and Loan Maturity — Critical date for the repayment of a $1.5 million note to Michael King and a $1.0 million loan, posing a significant liquidity risk if not met.
- 2025-04-16: Pinnacle Receivables Financing Agreement Balance — Indicates the outstanding balance of a key financing agreement, highlighting the company's reliance on external funding.
- 2025-05-29: Asset Purchase Agreement Date — Marks the execution of a future asset purchase, the financial impact of which is yet to be determined.
- 2024-11-01: Corporate Headquarters Lease Expiration — The lease for the main corporate office expires, necessitating potential lease renewal, renegotiation, or relocation.
Glossary
- Pinnacle Receivables Financing Agreement
- A type of financing where a company uses its accounts receivable as collateral to obtain funds. (Highlights a key source of funding for Charlie's Holdings and a potential area of financial risk if terms change or are not met.)
- Note Payable
- A written promise to pay a specific amount of money on demand or at a specified future date. (Indicates a debt obligation, with a specific note to Michael King due soon, representing a near-term financial commitment.)
- Asset Purchase Agreement
- A contract that transfers ownership of a specific asset or group of assets from a seller to a buyer. (Suggests potential future business activities or expansions, the financial implications of which are a factor for investors to consider.)
- Restricted Stock
- Stock granted to employees that has restrictions on its sale or transfer for a specified period. (Part of the company's incentive plan, its value and vesting schedule can impact future equity dilution and executive compensation.)
Year-Over-Year Comparison
Charlie's Holdings reported a net loss of $1.5 million for the three months ended March 31, 2025, a significant deterioration from the $0.9 million net loss in the same period of 2024. While specific revenue figures and margin changes are not detailed in the provided summary, the increased net loss suggests either declining revenues, rising costs, or a combination of both. New risks related to upcoming debt maturities and future asset purchase agreements have emerged as key concerns since the prior filing.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on June 27, 2025 by Michael King regarding Charlie's Holdings, Inc. (CHUC).